PubRank
Search
About
M D Lairmore
Author PubWeight™ 63.64
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway.
J Exp Med
1998
2.49
2
Selective ablation of human T-cell lymphotropic virus type 1 p12I reduces viral infectivity in vivo.
Blood
1998
2.03
3
Isolation from human placenta of the IgG transporter, FcRn, and localization to the syncytiotrophoblast: implications for maternal-fetal antibody transport.
J Immunol
1996
1.88
4
Functional role of pX open reading frame II of human T-lymphotropic virus type 1 in maintenance of viral loads in vivo.
J Virol
2000
1.61
5
Serological confirmation of human T-lymphotropic virus type I infection in healthy blood and plasma donors.
Blood
1989
1.47
6
Human T-lymphotropic virus type 1 p30(II) regulates gene transcription by binding CREB binding protein/p300.
J Virol
2001
1.42
7
Characterization of antibody reactivity to human T-cell lymphotropic virus types I and II using immunoblot and radioimmunoprecipitation assays.
J Clin Microbiol
1990
1.40
8
Human T-lymphotropic virus type 1 open reading frame I p12(I) is required for efficient viral infectivity in primary lymphocytes.
J Virol
2000
1.34
9
In vitro CD4+ lymphocyte transformation and infection in a rabbit model with a molecular clone of human T-cell lymphotrophic virus type 1.
J Virol
1996
1.33
10
Human T-lymphotropic virus type 1 p30(II) functions as a transcription factor and differentially modulates CREB-responsive promoters.
J Virol
2000
1.31
11
Human T-cell lymphotropic virus type 1 Tax mediates enhanced transcription in CD4+ T lymphocytes.
J Virol
1996
1.22
12
Endoplasmic reticulum and cis-Golgi localization of human T-lymphotropic virus type 1 p12(I): association with calreticulin and calnexin.
J Virol
2001
1.18
13
Comparative analysis of nucleotide sequences of the partial envelope gene (5' domain) among human T lymphotropic virus type I (HTLV-I) isolates.
Virology
1991
1.16
14
Experimental coinduction of type D retrovirus-associated pulmonary carcinoma and lentivirus-associated lymphoid interstitial pneumonia in lambs.
J Natl Cancer Inst
1987
1.16
15
HTLV-I-associated myelopathy associated with blood transfusion in the United States: epidemiologic and molecular evidence linking donor and recipient.
Neurology
1991
1.14
16
Differential replication and pathogenic effects of HIV-1 and HIV-2 in Macaca nemestrina.
AIDS
1994
1.10
17
Ovine lentivirus lymphoid interstitial pneumonia. Rapid induction in neonatal lambs.
Am J Pathol
1986
1.08
18
Proliferation response to interleukin-2 and Jak/Stat activation of T cells immortalized by human T-cell lymphotropic virus type 1 is independent of open reading frame I expression.
J Virol
1999
1.07
19
Three primary neoplasms in a goat: hepatocellular carcinoma, phaeochromocytoma and leiomyoma.
J Comp Pathol
1987
1.05
20
The etiology and pathogenesis of ovine pulmonary carcinoma (sheep pulmonary adenomatosis).
Vet Microbiol
1988
1.05
21
Quantification of human T-cell lymphotropic virus type 1 proviral load by quantitative competitive polymerase chain reaction.
J Virol Methods
1998
1.01
22
Enhanced human T-cell lymphotropic virus type I expression following induction of the cellular stress response.
Virology
1995
0.98
23
Serologic discrimination of human T cell lymphotropic virus infection by using a synthetic peptide-based enzyme immunoassay.
J Infect Dis
1991
0.98
24
In vitro cellular tropism of human T cell leukemia virus type 2.
AIDS Res Hum Retroviruses
2000
0.98
25
Evaluation of enzyme immunoassays for antibody to human T-lymphotropic viruses type I/II.
Lancet
1991
0.94
26
HTLV-I-associated myelopathy endemic in Texas-born residents and isolation of virus from CSF cells.
Neurology
1991
0.94
27
Humoral hypercalcemia of malignancy: severe combined immunodeficient/beige mouse model of adult T-cell lymphoma independent of human T-cell lymphotropic virus type-1 tax expression.
Am J Pathol
2001
0.93
28
The cellular stress response enhances human T-cell lymphotropic virus type 1 basal gene expression through the core promoter region of the long terminal repeat.
J Virol
1997
0.92
29
The human T-cell leukemia virus type 1 p13II protein: effects on mitochondrial function and cell growth.
Cell Death Differ
2005
0.91
30
Retrovirus-associated ovine pulmonary carcinoma (sheep pulmonary adenomatosis) and lymphoid interstitial pneumonia. I. Lesion development and age susceptibility.
Vet Pathol
1988
0.91
31
Lymphangiosarcoma in a young dog.
Vet Pathol
1996
0.90
32
Soluble recombinant HTLV-1 surface glycoprotein competitively inhibits syncytia formation and viral infection of cells.
Virus Res
2001
0.90
33
Analysis of antibody responses to phenotypically distinct lentiviruses.
J Clin Microbiol
1990
0.90
34
Simian immunodeficiency virus needlestick accident in a laboratory worker.
Lancet
1992
0.89
35
Mouse models of human T lymphotropic virus type-1-associated adult T-cell leukemia/lymphoma.
Vet Pathol
2010
0.88
36
Lesions and retroviruses associated with naturally occurring ovine pulmonary carcinoma (sheep pulmonary adenomatosis).
Vet Pathol
1988
0.87
37
Transcriptional regulation of parathyroid hormone-related protein promoter P3 by ETS-1 in adult T-cell leukemia/lymphoma.
Leukemia
2005
0.86
38
Signaling via the CD2 receptor enhances HTLV-1 replication in T lymphocytes.
Virology
1997
0.85
39
Transcriptional modulation of viral reporter gene constructs following induction of the cellular stress response.
Nucleic Acids Res
1997
0.84
40
Differential induction of tumor necrosis factor alpha in ovine pulmonary alveolar macrophages following infection with Corynebacterium pseudotuberculosis, Pasteurella haemolytica, or lentiviruses.
Infect Immun
1991
0.83
41
Infectious transmission of human T-cell lymphotropic virus type II in rabbits.
Blood
1991
0.83
42
Characterization of a HTLV-I-infected cell line derived from a patient with adult T-cell leukemia with stable co-expression of CD4 and CD8.
Leuk Res
1995
0.83
43
Familial adult T-cell leukemia/lymphoma.
Am J Hematol
1990
0.82
44
Oxytetracycline-associated nephrotoxicosis in feedlot calves.
J Am Vet Med Assoc
1984
0.81
45
Serologic confirmation of simian T-lymphotropic virus type I infection by using immunoassays developed for human T-lymphotropic virus antibody detection.
J Clin Microbiol
1992
0.81
46
Effects of whole blood lysis and fixation on the infectivity of human T-lymphotropic virus type 1 (HTLV-I).
Cytometry
1994
0.81
47
Pathogenesis of lymphoid interstitial pneumonia in natural and experimental ovine lentivirus infection.
Clin Infect Dis
1993
0.81
48
CD2 signalling induces phosphorylation of CREB in primary lymphocytes.
Immunology
1998
0.80
49
Repression of tax-mediated human t-lymphotropic virus type 1 transcription by inducible cAMP early repressor (ICER) protein in peripheral blood mononuclear cells.
J Med Virol
2000
0.80
50
Detection of simian T-lymphotropic virus type I using the polymerase chain reaction.
Int J Cancer
1992
0.80
51
Constitutive expression of c-jun and jun-B in cell lines infected with human T-lymphotropic virus types I and II.
Biochem Biophys Res Commun
1991
0.80
52
The effect of the cellular stress response on human T-lymphotropic virus type I envelope protein expression.
J Gen Virol
1998
0.79
53
Comparison of HTLV-I basal transcription and expression of CREB/ATF-1/CREM family members in peripheral blood mononuclear cells and Jurkat T cells.
J Acquir Immune Defic Syndr Hum Retrovirol
1999
0.79
54
Cellular immunity in dogs with keratoconjunctivitis sicca before and after treatment with topical 2% cyclosporine.
Vet Immunol Immunopathol
1995
0.79
55
Immunogenicity and conformational properties of an N-linked glycosylated peptide epitope of human T-lymphotropic virus type 1 (HTLV-I).
Biomed Pept Proteins Nucleic Acids
1995
0.78
56
Epidemiologic assessment of screening tests for antibody to human T lymphotropic virus type I (HTLV-I).
Am J Public Health
1990
0.78
57
Enhanced immunogenicity of a conformational epitope of human T-lymphotropic virus type 1 using a novel chimeric peptide.
Vaccine
2000
0.78
58
HTLV-I in Alaska Natives.
J Acquir Immune Defic Syndr
1993
0.77
59
Sexual transmission of simian T-lymphotropic virus type I: a model of human T-lymphotropic virus type I infection.
Leukemia
1994
0.77
60
Stimulation of the CD2 receptor pathway induces apoptosis in human T lymphotropic virus type I-infected cell lines.
J Acquir Immune Defic Syndr Hum Retrovirol
1996
0.77
61
Immune recognition of genetically diverse simian T-cell lymphotropic virus type I isolates.
Arch Virol
1995
0.77
62
Concomitant augmentation of CD4+ CD29+ helper inducer and diminution of CD4+ CD45RA+ suppressor inducer subset in patients infected with human T cell lymphotropic virus types I or II.
Clin Exp Immunol
1992
0.76
63
Prevalence of HTLV-I in Alaska Natives.
J Infect Dis
1990
0.76
64
Atypical human T-cell lymphotropic virus type-I-associated T-cell lymphoma in a low-prevalence Alaska Native population. Implications for disease surveillance.
Cancer
1993
0.75
65
Co-stimulation of human peripheral blood mononuclear cells with IL-2 and anti-CD3 monoclonal antibodies induces phosphorylation of CREB.
Immunol Lett
1998
0.75
66
Comparative biological features of a rat liver abscess model induced with three Fusobacterium necrophorum strains.
Am J Vet Res
1983
0.75
67
Seroprevalence of human T lymphotropic virus type I in Puerto Rico.
Am J Trop Med Hyg
1989
0.75
68
Glycosylation-dependent peptide antigenic determinants of env gp46 HTLV-1.
Leukemia
1995
0.75
69
Prospects for a human immunodeficiency virus/AIDS vaccine.
Dev Biol Stand
1990
0.75